Retraction Note to: Cancer Gene Therapy https://doi.org/10.1038/s41417-021-00332-6, published online 14 April 2021
The Editor-in-Chief has retracted this article because it contains material that substantially overlaps with the following article [1]. Qixin Leng, Xinyan Geng, Jiaxi He, Haowu Jiang and Rui Sun have informed the journal that they were not involved in this article or aware of its submission.
Qixin Leng, Xinyan Geng, Jiaxi He, Haowu Jiang and Rui Sun agree to this retraction. Songhui Xu does not agree to this retraction, or the wording of the retraction. Donge Tang and Yong Dai have not responded to any correspondence from the editor/publisher about this retraction.
Reference
Tang D-E, Dai Y, He J-X, Lin L-W, Leng Q-X, Geng X-Y, et al. Targeting the KDM4B–AR–c-Myc axis promotes sensitivity to androgen receptor-targeted therapy in advanced prostate cancer. J Pathol. 2020;252:101–13.e5495. https://doi.org/10.1002/path.5495.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Tang, D., He, J., Dai, Y. et al. Retraction Note: Targeting KDM1B-dependent miR-215-AR-AGR2-axis promotes sensitivity to enzalutamide-resistant prostate cancer. Cancer Gene Ther 30, 1442 (2023). https://doi.org/10.1038/s41417-023-00669-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41417-023-00669-0
